- Home
- ACIC vs OABI Comparison
ACIC vs OABI Comparison
Compare ACIC & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIC
- OABI
- Stock Information
- Founded
- ACIC 1999
- OABI 2012
- Country
- ACIC United States
- OABI United States
- Employees
- ACIC N/A
- OABI N/A
- Industry
- ACIC Property-Casualty Insurers
- OABI Biotechnology: Pharmaceutical Preparations
- Sector
- ACIC Finance
- OABI Health Care
- Exchange
- ACIC Nasdaq
- OABI Nasdaq
- Market Cap
- ACIC 514.2M
- OABI 532.9M
- IPO Year
- ACIC N/A
- OABI N/A
- Fundamental
- Price
- ACIC $11.02
- OABI $3.93
- Analyst Decision
- ACIC Buy
- OABI Strong Buy
- Analyst Count
- ACIC 1
- OABI 4
- Target Price
- ACIC $15.00
- OABI $9.00
- AVG Volume (30 Days)
- ACIC 206.3K
- OABI 383.8K
- Earning Date
- ACIC 11-11-2024
- OABI 11-07-2024
- Dividend Yield
- ACIC N/A
- OABI N/A
- EPS Growth
- ACIC N/A
- OABI N/A
- EPS
- ACIC 1.43
- OABI N/A
- Revenue
- ACIC $261,180,000.00
- OABI $21,714,000.00
- Revenue This Year
- ACIC N/A
- OABI N/A
- Revenue Next Year
- ACIC $13.95
- OABI $70.08
- P/E Ratio
- ACIC $7.73
- OABI N/A
- Revenue Growth
- ACIC N/A
- OABI N/A
- 52 Week Low
- ACIC $6.82
- OABI $3.56
- 52 Week High
- ACIC $14.38
- OABI $6.72
- Technical
- Relative Strength Index (RSI)
- ACIC 47.53
- OABI 34.72
- Support Level
- ACIC $10.79
- OABI $4.13
- Resistance Level
- ACIC $11.74
- OABI $4.38
- Average True Range (ATR)
- ACIC 0.37
- OABI 0.15
- MACD
- ACIC -0.01
- OABI -0.05
- Stochastic Oscillator
- ACIC 25.77
- OABI 1.20
About ACIC American Coastal Insurance Corporation
American Coastal Insurance Corp is a holding company that underwrites commercial residential property and casualty insurance policies in the United States through its wholly-owned insurance subsidiary. The company has two segments namely: Commercial Lines Business and Personal Lines Business. It derives maximum revenue from Commercial Lines Business Segment.
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. The company focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.